BC Innovations | Feb 5, 2015
Product R&D

Addex's allosterics

Allosteric modulators are slowly filling the clinical pipeline, but finding the right assays to discover and characterize them properly still confounds companies in the space. Addex Therapeutics Ltd. is going back to basics and forging...
BC Innovations | Jan 6, 2011
Distillery Therapeutics

Indication: Hematology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Hematology Hematological mobilization CXC chemokine receptor 4 (CXCR4; NPY3R) Studies in mice and in nonhuman primates suggest that the pepducin-based CXCR4 agonist ATI-2341 could help mobilize...
Items per page:
1 - 2 of 2